1. Home
  2. VERV vs SLQT Comparison

VERV vs SLQT Comparison

Compare VERV & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • SLQT
  • Stock Information
  • Founded
  • VERV 2018
  • SLQT 1999
  • Country
  • VERV United States
  • SLQT United States
  • Employees
  • VERV N/A
  • SLQT N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • SLQT Specialty Insurers
  • Sector
  • VERV Health Care
  • SLQT Finance
  • Exchange
  • VERV Nasdaq
  • SLQT Nasdaq
  • Market Cap
  • VERV 382.5M
  • SLQT 408.2M
  • IPO Year
  • VERV 2021
  • SLQT 2020
  • Fundamental
  • Price
  • VERV $4.79
  • SLQT $2.45
  • Analyst Decision
  • VERV Strong Buy
  • SLQT Hold
  • Analyst Count
  • VERV 4
  • SLQT 1
  • Target Price
  • VERV $25.75
  • SLQT $4.00
  • AVG Volume (30 Days)
  • VERV 1.4M
  • SLQT 1.2M
  • Earning Date
  • VERV 11-05-2024
  • SLQT 11-04-2024
  • Dividend Yield
  • VERV N/A
  • SLQT N/A
  • EPS Growth
  • VERV N/A
  • SLQT N/A
  • EPS
  • VERV N/A
  • SLQT N/A
  • Revenue
  • VERV $24,396,000.00
  • SLQT $1,381,309,000.00
  • Revenue This Year
  • VERV $84.66
  • SLQT $11.29
  • Revenue Next Year
  • VERV N/A
  • SLQT $14.41
  • P/E Ratio
  • VERV N/A
  • SLQT N/A
  • Revenue Growth
  • VERV 219.91
  • SLQT 28.72
  • 52 Week Low
  • VERV $4.31
  • SLQT $1.03
  • 52 Week High
  • VERV $19.34
  • SLQT $4.46
  • Technical
  • Relative Strength Index (RSI)
  • VERV 32.80
  • SLQT 59.54
  • Support Level
  • VERV $6.02
  • SLQT $1.92
  • Resistance Level
  • VERV $6.68
  • SLQT $2.65
  • Average True Range (ATR)
  • VERV 0.47
  • SLQT 0.16
  • MACD
  • VERV -0.14
  • SLQT 0.06
  • Stochastic Oscillator
  • VERV 0.25
  • SLQT 72.60

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

Share on Social Networks: